Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in Can J Cardiol Retrieve available abstracts of 99 articles: HTML format

Single Articles

September 2022
1. LUCYK SN
   Acute Cardiovascular Toxicity of Cocaine.
   Can J Cardiol. 2022;38:1384-1394.
   PubMed     Abstract available
   
   
   
2. D'ENTREMONT MA, Couture EL, Connelly K, Walling A, et al
   Management of the Master Endurance Athlete With Stable Coronary Artery Disease.
   Can J Cardiol. 2022;38:1450-1453.
   PubMed    
   
   
   
3. GAGNON LR, Sadasivan C, Perera K, Oudit GY, et al
   Cardiac Complications of Common Drugs of Abuse: Pharmacology, Toxicology, and Management.
   Can J Cardiol. 2022;38:1331-1341.
   PubMed     Abstract available
   
   
   August 2022
4. TERADA T, Cotie LM, Tulloch H, Mistura M, et al
   Sustained Effects of Different Exercise Modalities on Physical and Mental Health in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
   Can J Cardiol. 2022;38:1235-1243.
   PubMed     Abstract available
   
   
   
5. THOMPSON CR
   Acute Coronary Syndrome and Aortic Stenosis: A Lethal Combo!
   Can J Cardiol. 2022;38:1130-1131.
   PubMed    
   
   
   
6. PARLOW S, Weng W, Di Santo P, Jung RG, et al
   Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial.
   Can J Cardiol. 2022;38:1211-1219.
   PubMed     Abstract available
   
   
   
7. CHEW NWS, Zhang A, Ong J, Koh S, et al
   Long-term Prognosis in Patients With Concomitant Acute Coronary Syndrome and Aortic Stenosis.
   Can J Cardiol. 2022;38:1220-1227.
   PubMed     Abstract available
   
   
   
8. TEHRANI BN, Drakos SG, Billia F, Batchelor WB, et al
   The Multicenter Collaborative to Enhance Biologic Understanding, Quality, and Outcomes in Cardiogenic Shock (VANQUISH Shock): Rationale and Design.
   Can J Cardiol. 2022;38:1286-1295.
   PubMed     Abstract available
   
   
   
9. RAO K, Granger E, Dvir D, Fahmy P, et al
   BASILICA Technique for Prevention of Coronary Artery Occlusion in High-Risk Native Transcatheter Aortic Valve Replacement.
   Can J Cardiol. 2022;38:1312-1314.
   PubMed    
   
   
   July 2022
10. RAPARELLI V, Wright CX, Corica B, Sharma G, et al
    Interventions Targeted to Address Social Determinants of Health in Ischemic Heart Disease: A Sex- and Gender-Oriented Scoping Review.
    Can J Cardiol. 2022 Jul 6. pii: S0828-282X(22)00405.
    PubMed     Abstract available
    
    
    June 2022
11. LEUNG AA, Anderson TJ
    PCSK9 Inhibition Following Myocardial Infarction: A Right Time to Act.
    Can J Cardiol. 2022 Jun 23. pii: S0828-282X(22)00393.
    PubMed    
    
    
    
12. PIVATO CA, Jones D, Cao D, Sartori S, et al
    Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention.
    Can J Cardiol. 2022;38:792-800.
    PubMed     Abstract available
    
    
    
13. GNANENTHIRAN SR, Ng ACC, Cumming RG, Brieger DB, et al
    Hemoglobin, Frailty, and Long-term Cardiovascular Events in Community-Dwelling Older Men Aged >/= 70 Years.
    Can J Cardiol. 2022;38:745-753.
    PubMed     Abstract available
    
    
    May 2022
14. CHIANG CE, Schwartz GG, Elbez Y, Szarek M, et al
    Alirocumab and Cardiovascular Outcomes in Patients with Previous Myocardial Infarction: Prespecified Sub-analysis from ODYSSEY OUTCOMES.
    Can J Cardiol. 2022 May 26. pii: S0828-282X(22)00337.
    PubMed     Abstract available
    
    
    
15. CHAHDI HO, Berbach L, Boivin-Proulx LA, Hillani A, et al
    Percutaneous Mechanical Circulatory Support in Post-Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Can J Cardiol. 2022 May 25. pii: S0828-282X(22)00333.
    PubMed     Abstract available
    
    
    April 2022
16. MIDDLEKAUFF HR, Cooper ZD, Strauss SB
    Drugs of Misuse: Focus on Vascular Dysfunction.
    Can J Cardiol. 2022 Apr 21. pii: S0828-282X(22)00261.
    PubMed     Abstract available
    
    
    March 2022
17. PERRIN N, Avram R
    Invasive Management of Refractory Angina: Are We There Yet?
    Can J Cardiol. 2022;38:306-308.
    PubMed    
    
    
    
18. HOCHSTADT A, Itach T, Merdler I, Ghantous E, et al
    Effectiveness of Coronary Sinus Reducer for Treatment of Refractory Angina: A Meta-analysis.
    Can J Cardiol. 2022;38:376-383.
    PubMed     Abstract available
    
    
    
19. BOUCHER T, Shah AM, Hashim H, Jerschow E, et al
    Durable Polymer Drug Eluting Stent-Induced Kounis Syndrome and Eosinophilia Requiring Long-term Immunosuppression.
    Can J Cardiol. 2022;38:398-400.
    PubMed    
    
    
    
20. EMAMI M, Agbaedeng TA, Thomas G, Middeldorp ME, et al
    Accelerated Biological Aging Secondary to Cardiometabolic Risk Factors Is a Predictor of Cardiovascular Mortality: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2022;38:365-375.
    PubMed     Abstract available
    
    
    February 2022
21. MALHI N, Moghaddam N, Hosseini F, Singer J, et al
    Care and Outcomes of ST-Segment-Elevation Myocardial Infarction across multiple Coronavirus Disease 2019 (COVID-19) waves.
    Can J Cardiol. 2022 Feb 10. pii: S0828-282X(22)00089.
    PubMed     Abstract available
    
    
    January 2022
22. BOITARD SE, Keck M, Deloux R, Girault-Sotias PE, et al
    QGC606, a best-in-class orally active centrally acting aminopeptidase A inhibitor prodrug, for treating heart failure following myocardial infarction.
    Can J Cardiol. 2022 Jan 25. pii: S0828-282X(22)00069.
    PubMed     Abstract available
    
    
    
23. CHAVARRIA J, Sibbald M, Velianou J, Natarajan M, et al
    A Computed Tomography Protocol to Evaluate Coronary Artery Disease Before Transcatheter Aortic Valve Replacement.
    Can J Cardiol. 2022;38:23-30.
    PubMed     Abstract available
    
    
    
24. TANG H, Li Z, Fan Y, Zhang T, et al
    Differences in Culprit Lesions Between Premenopausal and Postmenopausal Women With Acute Coronary Syndrome: An Optical Coherence Tomography Study.
    Can J Cardiol. 2022;38:85-91.
    PubMed     Abstract available
    
    
    
25. LEBOUTTE PH, Demers P, Joubert P, Marquis-Gravel G, et al
    Percutaneous Management of Septic Left Anterior Descending Coronary Occlusion Following Minimally Invasive Surgery for Mitral Valve Infective Endocarditis.
    Can J Cardiol. 2022;38:126-128.
    PubMed     Abstract available
    
    
    
26. GALLONE G, Baldetti L, Angelini F, Saglietto A, et al
    The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials.
    Can J Cardiol. 2022;38:113-122.
    PubMed     Abstract available
    
    
    December 2021
27. DEL MONTE A, Marra MP, Cardaioli F, Gerosa G, et al
    Two left ventricular pseudoaneurysms complicating a myocardial infarction. The impact of cardiac magnetic resonance in the acute setting.
    Can J Cardiol. 2021 Dec 6. pii: S0828-282X(21)00918.
    PubMed     Abstract available
    
    
    
28. SAMUEL R, Alfadhel M, McAlister C, Nestelberger T, et al
    Coronary Events in the Pregnant Patient: Who Is at Risk and How Best to Manage?
    Can J Cardiol. 2021;37:2026-2034.
    PubMed     Abstract available
    
    
    
29. ZEN M, Marschner S, Szczeklik W, Roshanov PS, et al
    Association of Preeclampsia With Myocardial Injury Among Patients Undergoing Noncardiac Surgery: The PREECLAMPSIA-VISION Study.
    Can J Cardiol. 2021;37:1934-1941.
    PubMed     Abstract available
    
    
    November 2021
30. LEE M, Lee K, Kim DW, Cho JS, et al
    Relationship of serial hsCRP changes to long-term clinical outcomes in stabilized post myocardial infarction patients.
    Can J Cardiol. 2021 Nov 1. pii: S0828-282X(21)00808.
    PubMed     Abstract available
    
    
    
31. LEASURE M, Jain U, Butchy A, Otten J, et al
    Deep Learning Algorithm Predicts Angiographic Coronary Artery Disease in Stable Patients Using Only a Standard 12-Lead Electrocardiogram.
    Can J Cardiol. 2021;37:1715-1724.
    PubMed     Abstract available
    
    
    
32. MARQUIS-GRAVEL G, Goodman SG, Anderson TJ, Bell AD, et al
    Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians.
    Can J Cardiol. 2021;37:1837-1845.
    PubMed     Abstract available
    
    
    
33. MURAI K, Otsuka F, Yoneda S, Kataoka Y, et al
    Temporal Changes in Near-Infrared Spectroscopy Signals in Recurrent In-Stent Restenosis Attributable to Calcified Nodule.
    Can J Cardiol. 2021;37:1880-1881.
    PubMed    
    
    
    October 2021
34. BLUSZTEIN D, Teng P, Deuse T, Mahadevan VS, et al
    Shock, Thrombus, TAVR: A Challenging TAVR With Large Left-Ventricular Thrombus.
    Can J Cardiol. 2021;37:1668-1670.
    PubMed     Abstract available
    
    
    
35. GOSLING RC, Adam Z, Barmby DS, Iqbal J, et al
    The Impact of Virtual Fractional Flow Reserve and Virtual Coronary Intervention on Treatment Decisions in the Cardiac Catheter Laboratory.
    Can J Cardiol. 2021;37:1530-1538.
    PubMed     Abstract available
    
    
    
36. KOO CY, Lim AYN, Chan KH
    Recurrent Stent Thrombosis Secondary to Immunoglobulin G4-Related Disease.
    Can J Cardiol. 2021;37:1659-1660.
    PubMed     Abstract available
    
    
    
37. LUO T, Liu H, Chen B, Liu H, et al
    A Novel Role of Claudin-5 in Prevention of Mitochondrial Fission Against Ischemic/Hypoxic Stress in Cardiomyocytes.
    Can J Cardiol. 2021;37:1593-1606.
    PubMed     Abstract available
    
    
    
38. JOLICOEUR EM, Pelletier-Galarneau M
    Rubidium-82 Positron Emission Tomography With Intravenous Ergonovine to Diagnose Vasospastic Angina.
    Can J Cardiol. 2021;37:1661-1664.
    PubMed     Abstract available
    
    
    September 2021
39. CHEW NWS, Ow ZGW, Teo VXY, Heng RRY, et al
    The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2021;37:1450-1459.
    PubMed     Abstract available
    
    
    
40. MASTERSON CREBER R, Spadaccio C, Dimagli A, Myers A, et al
    Patient-Reported Outcomes in Cardiovascular Trials.
    Can J Cardiol. 2021;37:1340-1352.
    PubMed     Abstract available
    
    
    August 2021
41. VIKULOVA DN, Trinder M, Mancini GBJ, Pimstone SN, et al
    Familial Hypercholesterolemia, Familial Combined Hyperlipidemia and Elevated Lipoprotein(a) in Patients with Premature Coronary Artery Disease.
    Can J Cardiol. 2021 Aug 26. pii: S0828-282X(21)00657.
    PubMed     Abstract available
    
    
    
42. PATERSON I, Ramanathan K, Aurora R, Bewick D, et al
    Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team.
    Can J Cardiol. 2021;37:1260-1262.
    PubMed     Abstract available
    
    
    
43. ROSHANOV PS, Sessler DI, Chow CK, Garg AX, et al
    Predicting Myocardial Injury and Other Cardiac Complications After Elective Noncardiac Surgery with the Revised Cardiac Risk Index: The VISION Study.
    Can J Cardiol. 2021;37:1215-1224.
    PubMed     Abstract available
    
    
    
44. MARIUCCI E, Bonori L, Lovato L, Graziano C, et al
    Coronary Artery Aneurysms in Patients With Marfan Syndrome: Frequent, Progressive, and Relevant.
    Can J Cardiol. 2021;37:1225-1231.
    PubMed     Abstract available
    
    
    
45. CHIU S, Nayak R, Lin B, Duan L, et al
    Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome.
    Can J Cardiol. 2021;37:1191-1197.
    PubMed     Abstract available
    
    
    
46. ABOUKHOUDIR F, Najjar A, Moussa K, Habib G, et al
    A Thrombus on a Journey: A Massive Thrombus in Transit With Cerebral, Coronary, and Pulmonary Embolization.
    Can J Cardiol. 2021;37:1281-1282.
    PubMed     Abstract available
    
    
    July 2021
47. HADJADJ S, Marsit O, Paradis JM, Beaudoin J, et al
    Pathophysiology, Diagnosis, and New Therapeutic Approaches for Ischemic Mitral Regurgitation.
    Can J Cardiol. 2021;37:968-979.
    PubMed     Abstract available
    
    
    June 2021
48. XIE Y, Seidman MA
    Inflammatory Comments in Coronary Artery Disease: When to Suspect Polyarteritis Nodosa or Other Primary Systemic Vasculitis.
    Can J Cardiol. 2021;37:830-832.
    PubMed    
    
    
    
49. LAI J, Zhao L, Zhong H, Zhou J, et al
    Characteristics and Outcomes of Coronary Artery Involvement in Polyarteritis Nodosa.
    Can J Cardiol. 2021;37:895-903.
    PubMed     Abstract available
    
    
    
50. MA K, Qi L, Yuan J, Zhang B, et al
    Anatomic Repair of Left Main Coronary Artery Atresia: Coronary Ostioplasty With Autologous Pulmonary Artery.
    Can J Cardiol. 2021;37:887-894.
    PubMed     Abstract available
    
    
    May 2021
51. LIAUW SS, Luong L, Liu S, Atcha M, et al
    Clinical Presentation and Outcome of Patients Experiencing Homelessness Presenting with ST-Elevation Myocardial Infarction.
    Can J Cardiol. 2021 May 15. pii: S0828-282X(21)00247.
    PubMed     Abstract available
    
    
    April 2021
52. ALY S, Aguet J, Dragulescu A, Grosse-Wortmann L, et al
    Neonatal Myocardial Infarction in Association with Gestational Diabetes.
    Can J Cardiol. 2021 Apr 17. pii: S0828-282X(21)00211.
    PubMed     Abstract available
    
    
    
53. WELSH RC, Cantor WJ, Traboulsi M, Schampaert E, et al
    Primary Percutaneous Coronary Intervention and Application of the Pharmacoinvasive Approach Within ST-Elevation Myocardial Infarction Care Networks: CJC Supplement - 40 Years of Innovation in Interventional Cardiology in Canada.
    Can J Cardiol. 2021 Apr 7. pii: S0828-282X(21)00173.
    PubMed     Abstract available
    
    
    
54. MCDONALD M, Virani S, Chan M, Ducharme A, et al
    CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.
    Can J Cardiol. 2021;37:531-546.
    PubMed     Abstract available
    
    
    
55. YANG W, Zhang A, Han Y, Su X, et al
    Cyclin-Dependent Kinase Inhibitor 2b Controls Fibrosis and Functional Changes in Ischemia-Induced Heart Failure via the BMI1-p15-Rb Signalling Pathway.
    Can J Cardiol. 2021;37:655-664.
    PubMed     Abstract available
    
    
    March 2021
56. CHO SM, Austin PC, Ross HJ, Abdel-Qadir H, et al
    MACHINE LEARNING COMPARED TO CONVENTIONAL STATISTICAL MODELS FOR PREDICTING MYOCARDIAL INFARCTION READMISSION AND MORTALITY: A SYSTEMATIC REVIEW.
    Can J Cardiol. 2021 Mar 4. pii: S0828-282X(21)00129.
    PubMed     Abstract available
    
    
    
57. KAVSAK PA, Mondoux S, Worster A, Martin J, et al
    Misclassification of Myocardial Injury by a High-Sensitivity Cardiac Troponin I Assay.
    Can J Cardiol. 2021;37:523.
    PubMed    
    
    
    
58. YOON YH, Lee PH, Park TK, Lee JH, et al
    Technical Feasibility and Safety of Percutaneous Coronary Intervention for True Ostial Left Anterior Descending Artery-Chronic Total Occlusion.
    Can J Cardiol. 2021;37:458-466.
    PubMed     Abstract available
    
    
    
59. GRAVEL H, Behzadi P, Cardinal S, Barry H, et al
    Acute Vascular Benefits of Finnish Sauna Bathing in Patients With Stable Coronary Artery Disease.
    Can J Cardiol. 2021;37:493-499.
    PubMed     Abstract available
    
    
    February 2021
60. HILLANI A, Potter BJ
    Intracoronary Thrombus and No-Reflow: One Size to Fit All?
    Can J Cardiol. 2021;37:202-205.
    PubMed    
    
    
    
61. NGUYEN CH, Marzolini S, Oh P, Thomas SG, et al
    A Retrospective Comparison of Fitness and Exercise Progression in Patients With Coronary and Peripheral Artery Disease in Cardiac Rehabilitation.
    Can J Cardiol. 2021;37:260-268.
    PubMed     Abstract available
    
    
    
62. SEMSAR-KAZEROONI K, Dima D, Valiquette J, Berube-Dufour J, et al
    Early Mobilization in People With Acute Cardiovascular Disease.
    Can J Cardiol. 2021;37:232-240.
    PubMed     Abstract available
    
    
    
63. ALYAMANI M, Campbell S, Navarese E, Welsh RC, et al
    Safety and Efficacy of Intracoronary Thrombolysis as Adjunctive Therapy to Primary PCI in STEMI: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2021;37:339-346.
    PubMed     Abstract available
    
    
    January 2021
64. LAVIE CJ, Ozemek C, Grace SL
    More Evidence of Comprehensive Cardiac Rehabilitation Benefits, Even for All-Cause Mortality: Need to Increase Use Worldwide.
    Can J Cardiol. 2021;37:19-21.
    PubMed    
    
    
    
65. GOUDA P, Wang X, McGillion M, Graham MM, et al
    Underutilization of Perioperative Screening for Cardiovascular Events After Noncardiac Surgery in Alberta.
    Can J Cardiol. 2021;37:57-65.
    PubMed     Abstract available
    
    
    
66. YANG X, Du X, Ma K, Li G, et al
    Circulating miRNAs Related to Long-term Adverse Cardiovascular Events in STEMI Patients: A Nested Case-Control Study.
    Can J Cardiol. 2021;37:77-85.
    PubMed     Abstract available
    
    
    
67. HUANG R, Palmer SC, Cao Y, Zhang H, et al
    Cardiac Rehabilitation Programs for Chronic Heart Disease: A Bayesian Network Meta-analysis.
    Can J Cardiol. 2021;37:162-171.
    PubMed     Abstract available
    
    
    
68. BOHM P, Scharhag J, Egger F, Tischer KH, et al
    Sports-Related Sudden Cardiac Arrest in Germany.
    Can J Cardiol. 2021;37:105-112.
    PubMed     Abstract available
    
    
    
69. GAO C, Buszman P, Buszman P, Chichareon P, et al
    Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial.
    Can J Cardiol. 2021;37:122-130.
    PubMed     Abstract available
    
    
    December 2020
70. FARDMAN A, Oren D, Beigel R, Matetzky S, et al
    Reply to Culic et al: Covid-19 pandemic and possible rebound phenomenon in incidence of acute myocardial infarction.
    Can J Cardiol. 2020 Dec 13. pii: S0828-282X(20)31142.
    PubMed    
    
    
    November 2020
71. CULIC V, AlTurki A, Proietti R
    Covid-19 pandemic and possible rebound phenomenon in incidence of acute myocardial infarction.
    Can J Cardiol. 2020 Nov 16. pii: S0828-282X(20)31105.
    PubMed    
    
    
    
72. MARBACH JA, Alhassani S, Chong AY, MacPhee E, et al
    A Novel Protocol for Very Early Hospital Discharge After STEMI.
    Can J Cardiol. 2020;36:1826-1829.
    PubMed     Abstract available
    
    
    June 2020
73. SCOTT L JR, Li N
    From Neutrophil Calcium Sensor to Myocardial Remodelling-A Double-Edged Pathway Guided by the Inflammasome.
    Can J Cardiol. 2020;36:813-815.
    PubMed    
    
    
    
74. LIU Y, Lu C, Guo Q
    Recurrent Type III Kounis Syndrome: Will Anti-Immunoglobulin E Drug Be Another Option?
    Can J Cardiol. 2020;36:966.
    PubMed     Abstract available
    
    
    
75. RIKU S, Suzuki S, Jinno Y, Tanaka A, et al
    Coronary Drug-Eluting Stent Infection Complicated by Coronary Artery Aneurysm and Purulent Pericarditis: Complete Resolution Without Surgery.
    Can J Cardiol. 2020;36:967.
    PubMed     Abstract available
    
    
    
76. NAM MCY, Di Marco A, Ausami A, Markham H, et al
    Demarcation of Transient Regional Myocardial Edema in Endocrinopathy-Induced Takotsubo Cardiomyopathy on Cardiac Magnetic Resonance T1 Mapping.
    Can J Cardiol. 2020;36:968.
    PubMed    
    
    
    
77. MOULIN S, Thomas A, Arnaud C, Arzt M, et al
    Cooperation Between Hypoxia-Inducible Factor 1alpha and Activating Transcription Factor 4 in Sleep Apnea-Mediated Myocardial Injury.
    Can J Cardiol. 2020;36:936-940.
    PubMed     Abstract available
    
    
    
78. SCARPARO P, Wilschut J, Van Mieghem NM, Diletti R, et al
    Management of Septal Branch Perforation and Septal Hematoma During Retrograde Treatment of Coronary Chronic Total Occlusion Using Fat Embolization.
    Can J Cardiol. 2020;36:966.
    PubMed     Abstract available
    
    
    
79. FAN L, Lucking AJ, Kelion A, Sabharwal N, et al
    Aortic Pseudoaneurysm With Compression of Left Main Stem Following Aortic Valve Replacement.
    Can J Cardiol. 2020;36:968.
    PubMed    
    
    
    
80. WATERS DD
    Notes From the Cardiology Clinic: Facing Down the Dragons of Health Anxiety.
    Can J Cardiol. 2020;36:820-821.
    PubMed    
    
    
    
81. SANTORO G, Salerno G, Cappelli Bigazzi M, Golino P, et al
    Challenging Transcatheter Treatment of a "Complex" Refractory Congestive Heart Failure.
    Can J Cardiol. 2020;36:968.
    PubMed    
    
    
    
82. SATTLER K, El-Battrawy I, Gietzen T, Kummer M, et al
    Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial Infarction.
    Can J Cardiol. 2020;36:860-867.
    PubMed     Abstract available
    
    
    
83. RASHID M, Kontopantelis E, Kinnaird T, Curzen N, et al
    Association Between Hospital Cardiac Catheter Laboratory Status, Use of an Invasive Strategy, and Outcomes After NSTEMI.
    Can J Cardiol. 2020;36:868-877.
    PubMed     Abstract available
    
    
    
84. MORRIS PD, Gosling R, Rothman A, Iqbal J, et al
    Double-Kissing Nanocrush for Bifurcation Lesions: Development, Bioengineering, Fluid Dynamics, and Initial Clinical Testing.
    Can J Cardiol. 2020;36:852-859.
    PubMed     Abstract available
    
    
    
85. CRIMI G, Mandurino-Mirizzi A, Gritti V, Scotti V, et al
    Percutaneous Coronary Intervention Techniques for Bifurcation Disease: Network Meta-analysis Reveals Superiority of Double-Kissing Crush.
    Can J Cardiol. 2020;36:906-914.
    PubMed     Abstract available
    
    
    May 2020
86. MARC Y, Boitard SE, Balavoine F, Azizi M, et al
    Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure.
    Can J Cardiol. 2020;36:721-731.
    PubMed     Abstract available
    
    
    
87. FELDMAN RD
    Sex-Specific Determinants of Coronary Artery Disease and Atherosclerotic Risk Factors: Estrogen and Beyond.
    Can J Cardiol. 2020;36:706-711.
    PubMed     Abstract available
    
    
    
88. BLAIS C, Rochette L, Ouellet S, Huynh T, et al
    Complex Evolution of Epidemiology of Vascular Diseases, Including Increased Disease Burden: From 2000 to 2015.
    Can J Cardiol. 2020;36:740-746.
    PubMed     Abstract available
    
    
    
89. DE FARIA AP, Modolo R, Chichareon P, Chang CC, et al
    Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS.
    Can J Cardiol. 2020;36:747-755.
    PubMed     Abstract available
    
    
    April 2020
90. KIMURA Y, Kondo T, Mutsuga M, Morimoto R, et al
    Impella 5.0 for Cardiogenic Shock After Thrombectomy in a Patient With Intraventricular Thrombosis.
    Can J Cardiol. 2020 Apr 11. pii: S0828-282X(20)30327.
    PubMed     Abstract available
    
    
    
91. BEN-SHOSHAN J, Banai S
    Coronary Sinus Reducer and Left Ventricular Function.
    Can J Cardiol. 2020;36:474-475.
    PubMed    
    
    
    
92. ALHUMAID W, Paterson DI
    Drug-Induced Acute Coronary Syndrome: A New Cardiovascular Concern With Immune Checkpoint Inhibitors and the Need for a Prospective Registry.
    Can J Cardiol. 2020;36:455-456.
    PubMed    
    
    
    
93. MILLER DD
    Machine Intelligence for Management of Acute Coronary Syndromes: Neural or Nervous Times?
    Can J Cardiol. 2020;36:470-473.
    PubMed    
    
    
    
94. ZHANG YJ, Chen Y, Zhao X, Chang X, et al
    Coronary Arteritis and Periaortitis in IgG4-Related Disease.
    Can J Cardiol. 2020;36:589.
    PubMed     Abstract available
    
    
    
95. IANNATTONE PA, Zhao X, VanHouten J, Garg A, et al
    Artificial Intelligence for Diagnosis of Acute Coronary Syndromes: A Meta-analysis of Machine Learning Approaches.
    Can J Cardiol. 2020;36:577-583.
    PubMed     Abstract available
    
    
    
96. LI Z, Habbous S, Thain J, Hall DE, et al
    Cost-Effectiveness Analysis of Frailty Assessment in Older Patients Undergoing Coronary Artery Bypass Grafting Surgery.
    Can J Cardiol. 2020;36:490-499.
    PubMed     Abstract available
    
    
    
97. GALLONE G, Palmisano A, Baldetti L, Monti CB, et al
    Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction.
    Can J Cardiol. 2020;36:589.
    PubMed     Abstract available
    
    
    
98. CAUTELA J, Rouby F, Salem JE, Alexandre J, et al
    Acute Coronary Syndrome With Immune Checkpoint Inhibitors: A Proof-of-Concept Case and Pharmacovigilance Analysis of a Life-Threatening Adverse Event.
    Can J Cardiol. 2020;36:476-481.
    PubMed     Abstract available
    
    
    
99. LEI C, Huang Y, Yuan S, Chen W, et al
    Takayasu Arteritis With Coronary Artery Involvement: Differences Between Pediatric and Adult Patients.
    Can J Cardiol. 2020;36:535-542.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: